These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30035295)
1. Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma. Boyaci C; Behzatoğlu K Turk Patoloji Derg; 2019; 35(1):22-27. PubMed ID: 30035295 [TBL] [Abstract][Full Text] [Related]
2. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Volmar KE; Chan TY; De Marzo AM; Epstein JI Am J Surg Pathol; 2003 Sep; 27(9):1243-52. PubMed ID: 12960809 [TBL] [Abstract][Full Text] [Related]
3. Glucose transporter-1 expression in urothelial papilloma of the bladder. Lee JH; Kim YW; Chang SG Urol Int; 2005; 74(3):268-71. PubMed ID: 15812216 [TBL] [Abstract][Full Text] [Related]
5. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma. Cox R; Epstein JI Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490 [TBL] [Abstract][Full Text] [Related]
6. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma. Behzatoğlu K; Yörükoğlu K; Demir H; Bal N Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766 [TBL] [Abstract][Full Text] [Related]
7. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study]. Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826 [TBL] [Abstract][Full Text] [Related]
8. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma. Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109 [TBL] [Abstract][Full Text] [Related]
9. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia. Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670 [TBL] [Abstract][Full Text] [Related]
10. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions. Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711 [TBL] [Abstract][Full Text] [Related]
11. Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. Zhong M; Tian W; Zhuge J; Zheng X; Huang T; Cai D; Zhang D; Yang XJ; Argani P; Fallon JT; Epstein JI Am J Surg Pathol; 2015 Jan; 39(1):127-31. PubMed ID: 25118812 [TBL] [Abstract][Full Text] [Related]
12. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. Wasco MJ; Daignault S; Bradley D; Shah RB Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100 [TBL] [Abstract][Full Text] [Related]
13. Inverted variant of urothelial carcinoma of the urinary bladder: a report of three cases and a proposal for a new clinicopathologic entity. Terada T Int J Clin Exp Pathol; 2013; 6(4):766-70. PubMed ID: 23573325 [TBL] [Abstract][Full Text] [Related]
14. The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging. Idrees MT; Alexander RE; Kum JB; Cheng L Hum Pathol; 2013 Jul; 44(7):1223-32. PubMed ID: 23375647 [TBL] [Abstract][Full Text] [Related]
15. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features. Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813 [TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stain. Yamashita R; Yamaguchi R; Yuen K; Niwakawa M; Tobisu K Int J Urol; 2006 Nov; 13(11):1448-50. PubMed ID: 17083402 [TBL] [Abstract][Full Text] [Related]
17. PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall. Legesse T; Matoso A; Epstein JI Hum Pathol; 2019 Dec; 94():11-15. PubMed ID: 31669177 [TBL] [Abstract][Full Text] [Related]
18. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Fong A; Garcia E; Gwynn L; Lisanti MP; Fazzari MJ; Li M Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378 [TBL] [Abstract][Full Text] [Related]
19. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170 [TBL] [Abstract][Full Text] [Related]
20. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases. Lin O; Cardillo M; Dalbagni G; Linkov I; Hutchinson B; Reuter VE Mod Pathol; 2003 Dec; 16(12):1289-98. PubMed ID: 14681330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]